4/A//SEC Filing
Dar Zavain 4/A
Accession 0001209191-23-026049
CIK 0001601830other
Filed
Apr 27, 8:00 PM ET
Accepted
Apr 28, 4:34 PM ET
Size
5.3 KB
Accession
0001209191-23-026049
Insider Transaction Report
Form 4/AAmended
Dar Zavain
Director
Transactions
- Award
Class A Common Stock
2023-04-03+1,996→ 57,569 total
Footnotes (2)
- [F1]The shares were issued pursuant to the Issuer's Outside Director Compensation Policy.
- [F2]Includes a total of 35,008 shares received pursuant to a pro-rata distribution from Lux Ventures, of which the Reporting Person was a limited partner. The acquisition of such shares was exempt pursuant to Rule 16a-9 and was inadvertently excluded from the total amount of shares held on the original Form 4 filing.
Documents
Issuer
RECURSION PHARMACEUTICALS, INC.
CIK 0001601830
Entity typeother
Related Parties
1- filerCIK 0001852075
Filing Metadata
- Form type
- 4/A
- Filed
- Apr 27, 8:00 PM ET
- Accepted
- Apr 28, 4:34 PM ET
- Size
- 5.3 KB